Skip to main content

Military Health System

COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

Image of Two healthcare workers, wearing masks, adding the COVID-19 vaccine to syringes. Two healthcare workers, wearing masks, adding the COVID-19 vaccine to syringes

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

The COVID-19 vaccination program in the U.S. Army Central’s area of operations is underway.

“The COVID-19 vaccine has begun coming into theater,” said Army Brig. Gen. Justin Swanson, commanding general of the Army Reserve 310th Expeditionary Sustainment Command.

Swanson is also the deputy commanding general of 1st Theater Sustainment Command, which is based at Fort Knox, Kentucky, and also has a forward deployed headquarters established at Camp Arifjan in Kuwait. The forward deployed headquarters, which operates as an operational command post, or 1st TSC-OCP, is staffed with rotations from subordinate echelons of mobilized active-duty and reserve component units, providing sustainment and logistics support to U.S. forces in Afghanistan, Iraq, and Syria, as well as to units throughout the Middle East.

The 1st TSC, working hand-in-hand with 3rd Medical Command-Deployment Support, coordinated the transport and storage of the vaccine in theater. The initial tranche or portion of the vaccine arrived around mid-January and administration began shortly after its arrival.

Those who received the initial doses of vaccine were at the top of a prioritized list of personnel, which 1st TSC developed in accordance with the Department of Defense’s vaccine distribution guidance.

“Some of the soldiers, even on our staff have been vaccinated—but only our medical personnel at this point,” said Swanson, who is himself a COVID-19 survivor.

“The priority is the same here as it is in CONUS,” said the general, who before his 1993 commission, served as a combat medic in the Louisiana National Guard. “As the vaccines and the number of doses grows, we have built a prioritization model for our entire footprint.”

In addition to prioritizing medical personnel, other military personnel targeted in the first phase of vaccinations are in jobs where their interactions with other Soldiers make them particularly vulnerable, he said.

The second tranche of vaccines, scheduled to arrive in the near future, will serve as the second doses for personnel, who received the first tranche, he said. Then, subsequent tranches are set to vaccinate personnel in Afghanistan and other regions.

Army Col. Jennifer Marrast Host, the commander of 3rd MCDS's forward headquarters at Camp Arifjan, said the vaccination program in theater is a priority for every one of her “Desert Medic” Soldiers.

The 3rd MCDS is responsible for executing strategic medical operations across the entire U.S. Central Command area of responsibility.

According to the colonel, the vaccine administered by her soldiers is produced by Moderna, which requires two doses approximately 28 days apart.

"We watch someone very closely for about 15 minutes after the injection to make sure they are not having a negative response," she said. "After that, they are ready to get back to work." Marrast Host said the side effects are relatively minor.

"There might be some muscle aching, localized swelling or a low-grade fever-you might just feel under the weather," she said.

"It is more likely that you would have some of the side effects after the second dose, but it is also sometimes after the first one," she said.

The colonel said the most important consideration for rolling out the vaccine to specific regions or installations is the availability of freezers and refrigerators.

"The vaccine must be frozen as it is transported around," she said. "After it is thawed, it is good to be used for 30 days, as long it is kept refrigerated--but it cannot be moved.

Swanson said distribution of the COVID-19 vaccine and COVID-19 mitigation are top priorities for the 1st TSC.

"What the 1st TSC will do from a distribution standpoint—one of the things that we do as our mission set—we will move the vaccine just like any other commodity that we move—and we move all commodities across the battlefield,” he said.

“Once it comes into theater, we will move it where it needs to be—any of the countries or locations, where we have U.S. forces—or forces that we will provide the vaccine for,” he said. “We have already gone through the first couple tranches of distribution and that will continue to grow, as will the number of doses continue to grow.”

The vaccine is currently voluntary for military personnel, but Swanson’s staff have surveyed troops to ask who is uncomfortable with the vaccine and who is willing to receive it.

“The vaccine is voluntary, at this point,” he said. “We understand who will volunteer to take the vaccine and who won’t—and we are prepared to support, once doses of vaccine hit the ground.”

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: December 28, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery